Canaccord Genuity Group Inc.

0RLV.L·LSE
Compare
9.45−0.25 (−2.58%)today
At close: Nov 20, 2:04 PM GMT · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles about it in the 4Search index. Click a dot on the chart for the event and the news of that day.

Key statistics

Previous close9.70
Open9.45
Day range—
52-week range8.359.70
Off day high0.00%
Off 52-week high−2.58%
Volume2.00
Avg. volume (3M)1.00
Market cap—
EPS (TTM)—
Forward P/E—
P/E ratio (TTM)—
Dividend yield3.97% (0.3850)
Beta (5Y)1.69
Shares outstanding—
Short interest—
Earnings dateFeb 11, 2027
Analyst target—
Profit margin−4.21%

Against its peers

Compare in full ›
0RLV.L CDA.V NKC.F CAF.V CANG CAN
Market cap — 28.97M 991.53M 16.12M 73.84M 87.75M
P/E (TTM) — — — 8.5 — —
Forward P/E — — — — -1.1 -0.1
Price/book 2.0 -830.0 0.7 1.0 0.6 0.3
Dividend yield 3.97% — — — — —
1-year change +10.86% −5.56% +24.26% +6.25% −87.14% −86.48%
Today −2.58% −2.35% −2.31% 0.00% +9.76% −4.15%

The closest companies by business. Prices may be delayed up to 15 min.

Latest news

All 0RLV.L news ›
markets.businessinsider.com·Negative

Quantum-Si (QSI) Receives a Hold from Canaccord Genuity

In a report released today, Kyle Mikson CFA from Canaccord Genuity reiterated a Hold rating on Quantum-Si, with a price target of $1.00. According to TipRanks, Mikson CFA is a 5-star analyst with an average return of 17.6% and a 47.78%…

Quantisnow··2 outlets

Claritev Corporation Announces Participation in Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Live feedPRReleasevia QuantisnowClaritev Corporation Announces Participation in Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum ByQuantisnow·Nov 5, 2026 · 08:23:49 ET·Wall Street's wire, on your screen.Stocks in…

More from 1 other outlet
The Globe and Mail·Negative

Castle Biosciences (CSTL) Receives a Buy from Canaccord Genuity

This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer. Castle Biosciences (CSTL) Receives a Buy from Canaccord Genuity…

Markets Daily··3 outletsPositive

Sally Beauty (NYSE:SBH) Given New $25.00 Price Target at Canaccord Genuity Group

Posted by Tristan Rich on Nov 12th, 2026 Share on Twitter Share on Facebook Share on LinkedIn Share on Stocktwits Sally Beauty (NYSE:SBH – Free Report) had its price target hoisted by Canaccord Genuity Group fr

More from 2 other outlets

From the 4Search news index, newest first.

In the news

135mentions in 30 days
135with it in the headline
Mixedsentiment

Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 120 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use. How to use Finance